"Think about where you want to apply AI – documentation, patient engagement, revenue cycle, clinical trials – and go talk to ...

India, March 6 -- Post-covid Assam has been one of the fastest-growing states in India, with a nominal rate of growth of 13 per cent in 2024-25 and average per capita income growth of more than 10 per ...

And as we lean in further, AI is strengthening our advantage, enabling significantly more automation and value for our customers, embedding our products more deeply into their daily operations and ...

The therapeutic landscape for cutaneous T-cell lymphoma (CTCL) is undergoing a significant shift with the emergence of denileukin diftitox (Lymphir), the first systemic treatment ...

CNTY-813, lead beta islet cell therapy program as a potential functional cure for type 1 diabetes, in Investigational New Drug (IND)-enabling ...

Solving Industry Challenges with AI", took place in Barcelona. At the summit, Huawei Cloud unveiled its Industry AI Foundry, introduced the next-generation hybrid cloud offering Huawei ...

Acquisition positions Servier as a leader in pediatric low-grade glioma and expands its pipeline with programs targeting adult and pediatric ...

Kinaxis Inc. ( KXS:CA) Q4 2025 Earnings Call March 5, 2026 8:30 AM EST Good morning, and welcome to the Kinaxis Inc. Fiscal 2025 Fourth Quarter and Year-end Results Conference Call. [Operator ...

Company launches initiative to become a dedicated AI infrastructure partner for the biotechnology industry — to deploy secure, on-premises AI systems directly within client environments where ...